424B3PROSPECTUS
Jun 17, 2026Final prospectus0001213900-26-069508
All companies
Trade Onconetix Inc424B4Nov 15, 2024
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split Onconetix, Inc. prospectus filed on Form S-1 (S-1) Onconetix S-1/A amendment (amendment no. 1)
ON
Onconetix Inc
ONCOPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $3.5M1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-edgar, sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
ONCOPrice
$0.9489
24h
+0.53%
Valuation
$3.5M
24h volume
$140.79K
Type
IPO
Trade Onconetix IncNow trading publicly. Buy via a broker — opens in a new tab.
IPO Calendar · updated 1h ago
Onconetix Inc IPO public float & lock-up
Public float and locked shares extracted from Onconetix Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
11.62M
Public float
—
Locked
—
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001782107.
Revenue
—
Net income
-$14.03M
Gross margin
—
Cash
$25.75M
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross profit | $632.91K | $1.06M | -$1.13M | — | — |
| Operating income | -$17.86M | -$56.49M | -$36.03M | -$13.48M | -$3.42M |
| Net income | -$14.03M | -$58.69M | -$37.41M | -$13.42M | -$3.42M |
| R&D expense | — | $154.36K | $1.95M | $4.13M | $1.33M |
| Cash & equivalents | — | — | — | $25.75M | $1.93M |
| Total assets | $24.93M | $28.18M | $87.52M | $26.31M | $3.08M |
| Total liabilities | $9.16M | $18.57M | $21.88M | $3.92M | $1.64M |
| Shareholders' equity | — | $8.54M | -$5.6M | $22.39M | $1.45M |
About Onconetix Inc
Onconetix Inc is an operating company with a business profile centered on its products, services, customers, and execution strategy.
What the company does
- Operates with a business profile defined by its products, services, customers, and operating execution.
- Its durable fundamentals depend on demand for its products or services, margin structure, competitive position, management execution, and capital discipline.
- Primary company filings and official materials are the best source for detailed information about revenue drivers, risk factors, and operating strategy.
Business profile
Onconetix Inc should be evaluated through its durable business model: what it sells, who it serves, how it generates revenue, and how efficiently it can scale.
SEC IPO filings
Final prospectusEDGAR filings resolved from ONCO / CIK 0001782107.
Jun 16, 2026Effective9999999995-26-002024
Jun 9, 2026Filed0001213900-26-066400
424B3PROSPECTUS
May 12, 2026Final prospectus0001213900-26-054634
May 11, 2026Effective9999999995-26-001568
May 7, 2026Effective9999999995-26-001545
May 7, 2026Amended0001213900-26-053255
CORRESPfilename1.htm
May 7, 2026SEC correspondence0001213900-26-053206
UPLOADfilename1.pdf
May 5, 2026SEC correspondence0000000000-26-004583
Apr 28, 2026Filed0001213900-26-048535
Dec 23, 2025Effective9999999995-25-003904
424B3PROSPECTUS
Dec 23, 2025Final prospectus0001213900-25-125297
Latest Onconetix Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
U.S. SEC (via SEC Archives)May 19, 2026IPO context
Onconetix news filed with the SEC (Exhibit 99.1); not an IPO event, but strong company-specific capital-market/SEC context.
U.S. SEC (via SEC Archives)IPO context
SEC S-1 prospectus filing by Onconetix; relevant IPO/going-public registration-statement context.
U.S. SEC (via SEC Archives)IPO context
Company-specific amendment to an S-1 registration statement; relevant to IPO/registration context.
Onconetix Inc IPO — frequently asked questions
- When did Onconetix Inc go public?
- Onconetix Inc has already gone public and now trades publicly on Nasdaq under the ticker ONCO.
- Can I buy Onconetix Inc stock?
- Yes — Onconetix Inc is publicly traded on Nasdaq as ONCO. You can follow its live price, valuation and post-IPO performance above.
- What is Onconetix Inc's valuation?
- Onconetix Inc's most recent valuation tracked here is $3.5M, derived from live market prices.